Sopartec commercialises state-of-the-art technologies which meet the current and future needs of the market. The projects described in this section are available for licence or commercialisation (material transfer agreement, etc.).
Our technologies have been developed mainly by the Université catholique de Louvain, the Cliniques universitaires St-Luc and the Institut de Duve.
The technologies available for commercialisation have been grouped together by technology field and are described above.
If you would like further information regarding the technologies described please see the PDF file for a summary of the available technology by clicking on the link below the title of each technology.
If you do not find the information please contact our team.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new treatment for bone and cartilage reconstruction and reinforcement.
Promethera® Biosciences, a spin-off company of the Université catholique de Louvain, and Sopartec, the technology transfer office of the Université catholique de Louvain, presents a new hepatocyte-like cell in vitro model.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new urinary biomarker that enables an early and sensitive detection of renal dysfunction.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new tool for the differential diagnosis of rheumatic conditions.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new method for quantification of biomarkers on histopathological slides
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new tool permitting the unambiguous identification of bacteria in various samples.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new MRI tool permitting a diagnostic and therapeutic guidance in disorders involving hypoxia.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new therapeutic strategy for cardiovascular diseases.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new strategy to identify highly selective anticancer drugs through the integration of hypoxia early in the discovery process.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a unique patented technology to assist a patient\'s upper limbs in the rehabilitation process
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new faster and accurate method for real time brachytherapy dosimetry
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new bioreactof for mass production of high quality arbuscular mycorrhizal fungi inoculants
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new method for increasing the size of plants or plant organs
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents unique ultra-low-power technologies covered by several patents.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new biosensor for detection of molecules in biological samples based on impedance measurements.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents label-free electronic biosensors for detection of molecules in biological samples.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a unique patented technology to pattern a ferroelectric polymer storage medium while simultaneously decreasing its writing voltage to a few Volts only.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new multi-electrode pH and conductivity meter
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents ultra-high-integration-density technologies for fabrication multiple-level nano-memory cells and circuits.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new regenerable polymeric filter aids for beer filtration
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new methodology for fast and selective C-C coupling reactions
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents an innovative pencil composition.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a unique Electronic Semiconductor Characterization Tool
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new faster and accurate method for real time brachytherapy dosimetry
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new method for quantification of biomarkers on histopathological slides
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new MRI tool permitting a diagnostic and therapeutic guidance in disorders involving hypoxia.